Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ACRS
CRMD
Add up to 3 more stocks
ACRS
Aclaris Therapeutics, Inc.
-9.72%
$3.85-0.41Delayed quote: Oct 6, 2026, 1:15 PM EDT
Market Cap
$538.40M
52W Range
$1.74 - $6.60
CRMD
CorMedix Inc.
-0.96%
$7.19-0.07Delayed quote: Oct 6, 2026, 1:15 PM EDT
Market Cap
$564.07M
52W Range
$6.13 - $13.02
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 3.38 |
| Forward P/E | N/A | 14.53 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.32 | 1.22 |
| P/S Ratio | 65.51 | 1.22 |
| P/FCF Ratio | N/A | 2.25 |
| EV/EBITDA | N/A | 1.79 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 73.3% | 82.8% |
| Operating Margin | -975.9% | 47.0% |
| Net Margin | -921.5% | 40.5% |
| ROE | -60.8% | 40.6% |
| ROA | -42.1% | 20.7% |
| ROIC | -57.0% | 27.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.46 | 2.56 |
| Quick Ratio | 3.46 | 2.36 |
| Debt/Equity | 0.00 | 0.31 |
| Interest Coverage | N/A | 53.97 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.